SKI Market

Indian Indices

Nifty

24,565.35 -203.00
(-0.82%)

Sensex

80,599.91 -585.67
( -0.72%)

Bank Nifty

55,617.60 -344.35
( -0.62%)

Nifty IT

34,649.60 -652.00
( -1.85%)

Global Indices

Nasdaq

43,604.51 -547.48
(-1.24%)

Dow Jones

6,258.79 -101.60
(1.60%)

Hang Seng

40,837.80 -232.02
(-0.56%)

Nikkei 225

9,068.58 -64.23
(-0.70%)

Forex

USD-INR

87.57 0.14
(0.16%)

EUR-INR

100.09 -0.48
(-0.48%)

GBP-INR

115.87 -0.55
(-0.47%)

JPY-INR

0.58 0.00
(-0.74%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

506197

INE416D01022

100.3479373

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BLISSGVS

25.96

1832.49

EPS(TTM)

Face Value()

Div & Yield %

6.69

0.29

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	667.20	605.46	598.34	636.36	465.51	441.95
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	667.20	605.46	598.34	636.36	465.51	441.95
Other Income	36.22	33.50	50.77	35.37	17.68	37.00
Stock Adjustments	-6.63	6.36	-21.24	8.90	8.85	-2.37
Total Income	696.79	645.32	627.87	680.63	492.04	476.58
EXPENDITURE :
Raw Materials	339.47	305.83	293.66	352.84	262.15	234.36
Power & Fuel Cost	9.76	8.81	5.80	7.09	6.99	4.70
Employee Cost	99.42	82.59	72.54	65.06	58.61	44.02
Other Manufacturing Expenses	15.50	17.25	11.57	11.54	7.49	6.23
Selling & Administrative Expenses	76.23	66.73	66.90	67.07	36.90	36.23
Miscellaneous Expenses	28.61	64.52	36.48	32.45	10.76	13.88
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	568.98	545.74	486.95	536.05	382.90	339.42
Operating Profit	127.80	99.59	140.93	144.57	109.14	137.16
Interest	6.58	5.81	10.06	4.32	4.19	6.62
Gross Profit	121.22	93.78	130.87	140.25	104.95	130.54
Depreciation	27.05	23.52	15.17	13.85	13.76	8.83
Profit Before Tax	94.17	70.26	115.70	126.40	91.19	121.71
Tax	30.74	26.34	34.42	31.92	21.52	31.81
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-5.54	-6.72	-4.21	1.81	2.16	-2.44
Reported Net Profit	68.97	50.64	85.48	92.66	67.50	92.33
Extraordinary Items	-0.14	-25.47	0.26	2.09	-0.02	0.53
Adjusted Net Profit	69.11	76.11	85.22	90.57	67.52	91.80
Adjustment below Net Profit	-0.56	-0.15	-0.67	1.62	0.52	-0.26
P & L Balance brought forward	892.57	846.18	765.33	676.22	613.36	533.69
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	4.12	4.10	3.97	5.18	5.16	12.41
P & L Balance carried down	956.86	892.57	846.18	765.33	676.22	613.36
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	50.00	50.00	50.00	50.00	50.00	50.00
Dividend Per Share(Rs)	0.50	0.50	0.50	0.50	0.50	0.50
Earnings Per Share-Unit Curr	6.55	4.84	8.21	8.94	6.54	8.95
Earnings Per Share(Adj)-Unit Curr	6.55	4.84	8.21	8.94	6.54	8.95
Book Value-Unit Curr	100.47	94.41	89.96	82.12	73.26	66.21
Book Value(Adj)-Unit Curr	100.47	94.41	89.96	82.12	73.26	66.21

24,565.35 -203.00 (-0.82%)

80,599.91 -585.67 ( -0.72%)

55,617.60 -344.35 ( -0.62%)

34,649.60 -652.00 ( -1.85%)

43,604.51 -547.48 (-1.24%)

6,258.79 -101.60 (1.60%)

40,837.80 -232.02 (-0.56%)

9,068.58 -64.23 (-0.70%)

87.57 0.14 (0.16%)

100.09 -0.48 (-0.48%)

115.87 -0.55 (-0.47%)

0.58 0.00 (-0.74%)